1.       Schmiedl S, Fischer R, Ibanez L, Fortuny J, Klungel OH, Reynolds R, Gerlach R, Tauscher M, Thürmann P, Hasford J, Rottenkolber M. Utilisation and off-label prescriptions of respiratory drugs in children. PLoS One 2014 Sep 2 (9):e105110
(Impact factor 2013: 3,5. Rang in Multidisciplinary Sciences 8 von 55, Topjournal, 0,5 Punkte)

2.       Rottenkolber M, Rottenkolber D, Fischer R, Ibanez L, Fortuny J, Ballarin E, Sabate M, Ferrer P, Thürmann P, Hasford J, Schmiedl S. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD. Respir Med 2014 Aug;108(8):1075-1090
(Impact factor 2013: 2,9. Rang in Respiratory System 20 von 53, Standardjournal, 0,25 Punkte)

3.       Hofer TP, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Wright AK, Kerscher M, Nährig S, Huber RM, Fischer R, Ziegler-Heitbrock L. Decreased expression of HLA-DQ and HLA-DR on cells oft he monocytic lineage in cystic fibrosis. J Mol Med 2014 Aug 23: epub PMID 25146850
(Impact factor 2013: 4,7. Rang in Medicine, Research + Exp. 17 von 122, Topjournal, 0,5 Punkte)

4.       Wanka ER, Bayerstadler A, Heumann C, Nowak D, Jörres RA, Fischer R. Weather and air pollutants have an impact on patients with respiratory diseases and breathing difficulties in Munich, Germany. Int J Biometeorol Mar;58(2):249-262
(Impact factor 2013: 2,1. Rang in Meteorology 30 von 76, Standardjournal, 1 Punkt)

5.       Schiffl H, Fischer R, Lang SM: Assessment of dialysis dose in critically ill maintenance dialysis patients. Ther Apher Dial 2014 Jan: epub PMID 24417815
(Impact factor 2013: 1,5. Rang in Urology and Nephrology 46 von 75, Standardjournal, 0,25 Punkte)

6.       Weber K, Paolini M, Schmitz M, Fischer R, Coppenrath E, Huber R, Reiser M, Mueller-Lisse UG. Cystic fibrosis in adults: short-term and long-term reproducibility of the brody score for lung morphology in low-dose MDCT scans. RoFo 2014 Jan;186(1): 54-60
(Impact factor 2013: 2,0. Rang in Radiology, Nucl. Med. 50 von 121, Standardjournal, 0,25 Punkte)



7.       Zhao Z, Müller-Lisse U, Frerichs I, Fischer R, Möller Knut. Regional airway obstruction in cystic fibrosis determined by electrical impedance tomography in comparison with high resolution CT. Physiol Meas 2013 Nov;34(11):N107-114.
(Impact factor 2013: 1,7. Rang in Engineering, Biomedical 38 von 77, Standardjournal, 0,25 Punkte)

8.       Hebestreit H, Sauer-Heilborn A, Fischer R, Käding M, Mainz JG. Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation. J Cyst Fibros 2013 Dec;12(6):599-603.
(Impact factor 2013: 3,8. Rang in Respiratory System 10 von 53, Topjournal, 0,5 Punkte)

9.       Schiffl H, Lang SM, Fischer R. Acute kidney injury: marker or mediator of subsequent CKD?
Am J Kidney Dis 2013 Jan;61(1):184-5
(Impact factor 2013: 5,7. Rang in Urology and Nephrology 5 von 75, Topjournal, 2 Punkte)


10.   Fischer R, Wanka ER, Einhaeupl F, Voll K, Schiffl H, Lang SM, Gruß M, Ferrari U. Comparison of portable oxygen concentrators in a simulated airplane environment.
Respir Med. 2013 Jan;107(1): 147-9
(Impact factor 2013: 2,9.  Rang in Respiratory System 20 von 53, Standardjournal, 1 Punkt)

11.   Schiffl H, Lang SM, Fischer R. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy.
Int Urol Nephrol. 2013 Oct;45(5):1389-1386
(Impact factor 2013: 1,3. Rang in Urology and Nephrology 54 von 75, Standardjournal, 1 Punkt)


12.   Schiffl H, Fischer R. Clinical cause of presumed acute tubular necrosis requiring renal replacement therapy and outcome of critically ill patients: post hoc analysis of a prospective 7-year cohort study.
Int Urol Nephrol. 2012 Dec;44(6):1779-89
(Impact factor 2012: 1,3. Rang in Urology and Nephrology 53 von 73, Standardjournal, 1 Punkt)

13.   Assael BM, Pressler T, Bilton D, Fayon M, Fischer R, Chiron R, Larosa M, Knoop C, McElvaney N, Lewis SA, Bresnik M, Montgomery AB, Oermann CM; For the AZLI Active Comparator Study Group. Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial.
J Cyst Fibros. 2012 Sep 14:S1569-1993
(Impact factor 2012: 2,9. Rang in Respiratory System 16 von 50, Standardjournal, 0,25 Punkte)

14.   Zhao Z, Fischer R, Müller-Lisse U, Moeller K. Ventilation inhomogeneity in patients with cystic fibrosis measured by electrical impedance tomography.
Biomed Tech (Berl). 2012 Sep 4 (epub)
(Impact factor 2012: 1,6. Rang in Engineering, Biomedical 57 von 79, Standardjournal, 0,25 Punkte)

15.   Zhao Z, Fischer R, Frerichs I, Müller-Lisse U, Möller K. Regional ventilation in cystic fibrosis measured by electrical impedance tomography.
J Cyst Fibros. 2012 Sep;11(5):412-8
(Impact factor 2012: 2,9. Rang in Respiratory System 16 von 50, Standardjournal, 0,25 Punkte)

16.   Aitken ML, Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, Haarman EG, Hebestreit HU, Lapey A, Schou IM, Zuckerman JB, Charlton B; CF302 Investigators. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Am J Respir Crit Care Med. 2012 Mar 15;185(6):645-52
(Impact factor 2012: 11,0. Rang in Respiratory System 1 von 50, Topjournal, 0,25 Punkte)

17.   Riepl RL, Fischer R, Hautmann H, Hartmann G, Müller TD, Tschöp M, Toepfer M, Otto B. Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptides.
PLoS One. 2012;7(9):e44445
(Impact factor 2012: 3.7. Rang in Multidisciplinary Sciences 7 von 56, Topjournal, 0,25 Punkte)


18.   Stern M, Niemann N, Wiedemann B, Wenzlaff P. Benchmarking improves quality in cystic fibrosis care: a pilot project involving  12 centres.
Int J Qual Health Care 2011 Jun 349-56.
Collaborators: Ballmann M, Dockter G, Feickert HJ, Fischer R, Kamin ES, Ko, Rietschel E, Schmidt S, Staab D, Tinschmann P, Skopnik H, Szczepanski R, Bergmann I.

(Impact faktor 2011: 2.0. Rang in Health Care .Sciences 33 von 76, Standardjournal, 0,25 Punkte)


19.   Geller DE, Flume PA, Staab D, Fischer R, Loutit JS, Conrad DJ; Mpex 204 Study Group. Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa.
Am J Respir Crit Care Med 2011 Jun 183(11):1510-6.
(Impact factor 2011: 11,1. Rang in Respiratory System 1 von 48, Topjournal, 0,25 Punkte)


20.   Naehrig S, Lang S, Schiffl H, Huber RM, Fischer R. Lung function in adult patients with cystic fibrosis after using the eFlow rapid for one year.
Eur J Med Res. 2011 Feb 24;16(2):63-6.

(Impactfactor 2011: 0,9. Rang in Medicine & Research 87 von 112, Standardjournal, 1 Punkt)

21.   Anzeneder L, Kircher F, Feghelm N, Fischer R, Seissler J. Kinetics of insulin  secretion and glucose intolerance in adult patients with cystic fibrosis.
Horm Metab Res. 2011 May;43(5):355-60.
(Impact factor 2011: 2,2. Rang Endocrinology & Metabolism 72 / 122, Standardjournal, 0,25 Punkte)


22.   Ferrari U, Exner T, Wanka ER, Bergemann C, Meyer-Arnek J, Hildenbrand B, Tufman A, Heumann C, Huber RM, Bittner M, Fischer R. Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany. Int J Biometeorol.  2011 Jan;56(1):137-43
(Impact factor 2011: 1,8. Rang in Meteorology 26 von 63, Standardjournal, 1 Punkt)




23.   Lippl FJ, Neubauer S, Schipfer S, Lichter N, Tufman A, Otto B, Fischer R. Hypobaric hypoxia causes body weight reduction in obese subjects.
Obesity 2010 Apr;18(4):675-81.
(Impact factor 2010: 3,36. Rang in Nutrition and Dietetics 12 von 70, Topjournal, 2 Punkte)

24.   Dressel H, Müller F, Fischer R, Römmelt H, Hohlfeld JM, Behr J, Huber RM, Nowak D, Jörres RA. Independent information of nonspecific biomarkers in exhaled  breath condensate.
Respiration. 2010 Aug 80(5):401-9.
(Impact factor 2010: 2,5. Rang in Respiratory System 19 von 46, Standardjournal, 0,25 Punkte)




25.   Fischer R, Nährig S, Kappler M, Griese M. Betreuung von Mukoviszidose-Patienten beim Übergang vom Jugendalter zum Erwachsenen.
Der Internist 2009, 50:1213-1220.
(Impact factor 2009: 0,3. Rang in Medicine & Internal 112 von 133, sonstiges Journal, kein Punkt)

26.   Gutt B, Wiesmeth A, Thurm U, Siegmund T, Schumm-Draeger PM, Fischer R. Extreme mountain climbing with type 1 diabetes.
Sportverletz Sportschaden. 2009 Mar;23(1):16-20.
(Impact factor 2009: 0,4. Rang in Orthopedics 45 von 56, Standardjournal, 1 Punkt


27.   Dressel H, Filser L, Fischer R, Marten K, Müller-Lisse U, de la Motte W, Nowak D,  Huber RM, Jörres RA. Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.
BMC Pulmonary Medicine 2009, 9:30
(Impact factor 1,85, bisher nicht in ISI gelistet, sonstiges Journal, kein Punkt)




28.   Dressel H, Filser L, Fischer R, de la Motte D, Steinhaeusser W, Huber RM, Nowak D, Jörres RA. Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time. Chest 2008 May 133(5):1149-54-7.
(Impact factor 2008: 5,2. Rang in Respiratory System 4 von 40, Topjournal, 0,25 Punkte)

29.   Kellner J, Tantzscher J, Oelmez H, Edelmann M, Fischer R, Huber RM, Bergner A. Mechanisms Altering Airway Smooth Muscle Cell Ca Homeostasis in Two Asthma Models.
Respiration. 2008 May 28.
(Impact factor 2008: 1,9. Rang in Respiratory System 22 von 40, Standardjournal, 0,25 Punkte)


30.   Schiffl H, Fischer R. Five-year outcomes of severe acute kidney injury requiring renal replacement therapy.
Nephrol Dial Transplant. 2008 Jul;23(7):2235-41.
(Impact factor 2008: 3,6. Rang in Urology and Nephrology 11 von 57, Topjournal, 2 Punkte)






31.   Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM.
Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
Pediatr Pulmonol. 2007 Dec;42(12):1193-7.
(Impact factor 2007:  2,3. Rang in Pediatrics 15 von 78, Topjournal, 2 Punkte)



32.   Lang SM, Becker A, Fischer R, Huber RM, Schiffl H
Acute effects of hemodialysis on lung function in patients with end-stage renal disease.
Wien Klin Wochenschr. 2006 Mar;118(3-4):108-13.
(Impact factor 0,9)

33.   Bergner A, Kellner J, Kemp da Silva A, Fischer R, Gamarra F, Huber RM.
Bronchial hyperreactivity is correlated with increased baseline airway tone.
Eur J Med Res 2006 Feb ;21(11):77-84
(Impact factor 1,25)




34.   Fischer R, Lang SM, Bergner A, Huber RM.
Monitoring of Expiratory Flow Rates and Lung Volumes during a High Altitude Expedition.
Eur J Med Res 2005 Nov ;11(10):469-474          
(Impact factor 1,25)


35.   Fischer R, Lang SM, Bruckner K, Hoyer HX, Meyer S, Griese M, Huber RM.
Lung function in adults with cystic fibrosis at altitude: impact on air travel.
Eur Respir J. 2005 Apr 25(4):718-24.
(Impact factor 3,10) 


36.   Hartl D, Starosta V, Maier K, Beck-Speier I, Rebhan C, Becker BF, Latzin P, Fischer R, Ratjen F, Huber RM, Rietschel E, Krauss-Etschmann S, Griese M.
Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
Free Radic Biol Med. 2005 Aug 15;39(4):463-72
(Impact factor 5,65)




37.   Fischer R, Lang SM, Leitl M, Thiere M, Steiner U, Huber RM.
Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude.
Eur Respir J. 2004 Jan ;23(1):47-52. 
(Impact factor 3,10)


38.   Fischer R, Vollmar C, Thiere M, Born C, Leitl M, Pfluger T, Huber RM.
No evidence of cerebral oedema in severe acute mountain sickness.
Cephalalgia. 2004 Jan ;24(1):66-71. 
(Impact factor 3,13)


39.   Henke MO, Lang SM, Fischer R, Landgraf R, Huber RM, Bertele-Harms RM, Harms HK. Diagnosis and therapy of cystic fibrosis-related diabetes.
Pneumologie. 2004 Jan;58(1):36-9
(Impact factor nicht verfügbar)


40.   Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Mullinger B, Huber RM, Maier K, Rietschel E, Scheuch G.
Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis.
Am J Respir Crit Care Med. 2004 Apr 1;169(7):822-8.
(Impact factor 8,12) 


41.   Lang SM, Fischer R, Stratakis DF, Huber RM.
High prevalence of osteoporosis in adult cystic fibrosis patients
Dtsch Med Wochenschr. 2004 Jul 9;129(28-29):1551-5.
(Impact factor 0,55)

42.   Coppenrath E, Mueller-Lisse UG, Lechel U, Veit R, Weber C, Banac S, Eibel R, Bitterling H, De Lorenzo C, Fischer R, Meindl T, Reiser M.
Niedrigdosis-Spiral-CT des Thorax in der Verlaufskontrolle nichtmaligner Lungenerkrankungen.
Fortschr Röntgenstr 2004; 176: 522-528
(Impact factor 1,76)



43.   Schiffl H, Lang SM, Fischer R
Stopping smoking slows accelerated progression of renal failure in primary renal disease.
J Nephrol. 2002 May-Jun ;15(3):270-4. 
(Impact factor 0,97)

44.   Schiffl H, Lang SM, Fischer R
Daily hemodialysis and the outcome of acute renal failure.
N Engl J Med. 2002 Jan 31;346(5):305-10.
(Impact factor 51,3)


45.   Schiffl H, Lang SM, Fischer R
Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients.
Nephrol Dial Transplant. 2002 Oct ;17(10):1814-8.
(Impact factor 2,57)




46.   Schiffl H, Lang SM, Stratakis D, Fischer R
Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters.
Nephrol Dial Transplant. 2001 Sep ;16(9):1863-9.
(Impact factor 2,43)




47.   Fischer R, Lang SM, Steiner U, Toepfer M, Hautmann H, Pongratz H, Huber RM.
Theophylline improves acute mountain sickness.
Eur Respir J. 2000 Jan ;15(1):123-7. 
(Impact factor 2,59)


48.   Schiffl H, Fischer R, Lang SM, Mangel E
Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
Nephrol Dial Transplant. 2000 Jun ;15(6):840-5.
(Impact factor 2,06)

49.   Schiffl H, Lang SM, Fischer R, Bergner A. Cigarette smoking accelerates progression of renal failure in primary renal disease. A prospective study in parallel group design with matched groups.
Nephrology 2000;5:151-154
(Impact factor 0,30)


50.   Hartmann G, Tschop M, Fischer R, Bidlingmaier C, Riepl R, Tschop K, Hautmann H, Endres S, Toepfer M.
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000 Mar ;12(3):246-52.
(Impact factor 2,49)


51.   Tschop M, Strasburger CJ, Topfer M, Hautmann H, Riepl R, Fischer R, Hartmann G, Morrison K, Appenzeller M, Hildebrandt W, Biollaz J, Bartsch P.
Influence of hypobaric hypoxia on leptin levels in men.
Int J Obes Relat Metab Disord. 2000 Jun ;24 Suppl 2:S151.
(Impact factor 2,98)



52.   Willner J, Flentja M, Schmidt M, Wirtz H, Huber RM, Fischer R, Lang S.
Sequentielle Chemo- und Radiotherapie mit Paclitaxel/Carboplat und 3D-konformer Bestrahlung beim inoperablen nichtkleinzelligen Bronchialkarzinom.
Strahlentherapie und Onkologie 1998, 174, Suppl I:15-18
(Impact factor für 1998 nicht verfügbar)



53.   Huber RM, Fischer R, Hautmann H, Pollinger B, Häußinger K, Wendt T.
Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):533-40.
(Impact factor 3,00)


54.   Huber RM, Fischer R, Hautmann H, Pollinger B, Wendt T, Muller-Wening D, Häußinger K.
Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules.
Chest. 1995 Feb;107(2):463-70.
(Impact factor 2,48)


55.   Fischer R, Huber RM, Wendt T, Häußinger K. Das adenoidzystische Karzinom: Behandlungsmöglichkeiten mit der High-Dose-Rate-Brachytherapie.
Atemwegs- und Lungenkrankheiten 1995, 21:350-351



56.   Fischer R
Zur perioperativen Krankheitsbewältigung bei malignen Neoplasien der weiblichen Fortpflanzungsorgane und der Mamma.
Inauguraldissertation, Ludwig-Maximilians-Universität München 1995

Pneumologische Praxis München-West | praxis@rainald.de